The New York Entrepreneur

Vertex’s stock climbs as non-opioid pain treatment advances

Read Time:6 Second

Vertex Pharmaceuticals shares gained ground early Thursday after the company signaled progress in the development of its experimental non-opioid pain treatment.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %

Average Rating

5 Star
0%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous post CSX ‘solid and steady’ despite Baltimore bridge collapse, say analysts
Next post Philly Fed factory gauge jumps to highest level in two years in April